Maude Richard J, Yunus Emran Bin, Hoque Gofranul, Hassan Mahtab Uddin, Hossain Amir, Samad Rasheda, Rahman Ridwanur, Ghose Aniruddha, Day Nicholas P, White Nicholas J, Dondorp Arjen M, Faiz M Abul
Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
J Chittagong Med Coll Teach Assoc. 2010 May;20(1):2-5. doi: 10.3329/jcmcta.v20i1.4926.
Chittagong Medical College and Hospital (CMCH) in Chittagong, Bangladesh, and Mahidol-Oxford Tropical Medicine Research Unit (MORU) of Bangkok, Thailand, are partners in a highly successful and productive research collaboration that is now heading into its tenth year. It produced arguably one of the most important clinical trials in tropical medicine this decade, the South-East-Asia-Quinine-Artesuante-Malaria-Trial (SEAQUAMAT) study, and has continued to evolve and grow ever since. The collaboration has successfully completed a number of significant clinical studies which have given important new insights into the management and pathogenesis of malaria and, to date, generated 14 peer-reviewed international journal publications. With each passing year, the size of the collaboration continues to increase along with the number and complexity of research studies undertaken. It has also helped to provide valuable postgraduate training to develop clinical services and increase capacity for high quality research in Bangladesh. The partners have complementary knowledge, skills and expertise and share common goals and it is hoped that this will remain a highly successful collaboration long into the future.
位于孟加拉国吉大港市的吉大港医学院及医院(CMCH)与泰国曼谷的玛希隆大学-牛津热带医学研究中心(MORU)是合作伙伴,双方开展了一项极为成功且成果丰硕的研究合作,如今已步入第十个年头。该合作开展了本十年热带医学领域最重要的临床试验之一——东南亚奎宁-蒿甲醚-疟疾试验(SEAQUAMAT)研究,此后不断发展壮大。合作已成功完成多项重要临床研究,这些研究为疟疾的管理和发病机制提供了重要的新见解,截至目前已在同行评审的国际期刊上发表了14篇论文。年复一年,合作规模不断扩大,开展的研究数量和复杂性也与日俱增。它还为孟加拉国培养临床服务人才、提高高质量研究能力提供了宝贵的研究生培训。合作伙伴拥有互补的知识、技能和专业知识,且目标一致,希望这种合作在未来很长一段时间内仍将非常成功。